<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Thanks to the use of drugs released in hydrogels, pharmaceutical aspects can increase productivity, profitability and wide range of applications [
 <xref rid="B70-nanomaterials-09-00404" ref-type="bibr" class="xref">70</xref>]. One example of an insulin delivery system is a hydrogel comprising an insulin-containing reservoir within a poly (methacrylic acid-g-ethylene glycol) copolymer in which glucose oxidase was immobilized [
 <xref rid="B168-nanomaterials-09-00404" ref-type="bibr" class="xref">168</xref>,
 <xref rid="B169-nanomaterials-09-00404" ref-type="bibr" class="xref">169</xref>]. Currently, there is a limited research on fluorinated polymers as a drug carrier in drug delivery applications. Polymer membranes have been used as passive materials for drug release due to their ability to be hydrophilic to hydrophobic in surface wettability. The characteristics of the process are reversible and can go to the initial state [
 <xref rid="B170-nanomaterials-09-00404" ref-type="bibr" class="xref">170</xref>,
 <xref rid="B171-nanomaterials-09-00404" ref-type="bibr" class="xref">171</xref>]. The use of lipid based biopolymers for cancer therapy has been recently reviewed [
 <xref rid="B172-nanomaterials-09-00404" ref-type="bibr" class="xref">172</xref>]. In this article, authors have focused on the advantageous biologic and physicochemical characteristics including controlled drug release, long circulatory half-lives and facile targeted therapy of the natural and synthetic lipid. 
</p>
